Maintenance Strategies: Continuing Low-Dose or Stepping Off Many patients achieve weight-loss goals and transition to a lower maintenance dose rather than stopping entirely
10.1111/dom.12414 34 HusainM.BirkenfeldA
Originally developed for type 2 diabetes, medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have produced substantial weight loss in clinical trials
Gezondheid van het hart: sommige studies tonen aan dat L-carnitine de bloeddruk kan verlagen en het ontstekingsproces kan verminderen dat gepaard gaat met hartaandoeningen
Both studies noted that their findings were preliminary, and larger double-blind controlled studies are needed to confirm the results
A recent survey by Numerator cited by Morgan Stanley revealed startling numbers for the health-conscious a survey of over 90,000 households in January revealed that 12.3% of households had a family member using a GLP-1 drug, up from 11.4% in October